Dr. Mark Kris, MD

Claim this profile

Memorial Sloan Kettering Cancer Center

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
2 reported clinical trials
4 drugs studied

Area of expertise

1Lung Cancer
Mark Kris, MD has run 2 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
RET positive
AXL positive
2Non-Small Cell Lung Cancer
Mark Kris, MD has run 1 trial for Non-Small Cell Lung Cancer. Some of their research focus areas include:
RET positive
AXL positive
ROS1 positive

Affiliated Hospitals

Image of trial facility.
Memorial Sloan Kettering Cancer Center

Clinical Trials Mark Kris, MD is currently running

More about Mark Kris, MD

Clinical Trial Related7 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Mark Kris, MD has experience with
  • Cabozantinib
  • Etoposide
  • Osimertinib
  • Platinum

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Mark Kris, MD specialize in?
Is Mark Kris, MD currently recruiting for clinical trials?
Are there any treatments that Mark Kris, MD has studied deeply?
What is the best way to schedule an appointment with Mark Kris, MD?
What is the office address of Mark Kris, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security